- Home
- SCSC vs ORGO Comparison
SCSC vs ORGO Comparison
Compare SCSC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCSC | ORGO |
|---|---|---|
| Founded | 1992 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 909.7M | 732.3M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCSC | ORGO |
|---|---|---|
| Price | $40.38 | $3.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $43.00 | $8.00 |
| AVG Volume (30 Days) | 158.6K | ★ 885.3K |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $3,004,880,000.00 | $465,218,000.00 |
| Revenue This Year | $5.40 | $8.14 |
| Revenue Next Year | $5.34 | $6.33 |
| P/E Ratio | $12.73 | ★ N/A |
| Revenue Growth | N/A | ★ 2.24 |
| 52 Week Low | $28.75 | $2.61 |
| 52 Week High | $51.66 | $7.08 |
Technical Indicators
Market Signals| Indicator | SCSC | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 35.72 |
| Support Level | $39.34 | $3.60 |
| Resistance Level | $41.78 | $4.10 |
| Average True Range (ATR) | 1.08 | 0.18 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 53.46 | 29.17 |
Price Performance
Historical ComparisonAbout SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.